LIMN fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Liminatus Pharma, Inc. is a pre-clinical-stage immuno-oncology company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in La Palma, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
LIMN has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company